A detailed history of Decision Point Financial, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Decision Point Financial, LLC holds 72 shares of JNJ stock, worth $14,369. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72
Previous 330 78.18%
Holding current value
$14,369
Previous $50,000 74.0%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$155.17 - $185.42 $40,033 - $47,838
-258 Reduced 78.18%
72 $13,000
Q2 2025

Aug 13, 2025

BUY
$146.36 - $159.82 $2,927 - $3,196
20 Added 6.45%
330 $50,000
Q1 2025

May 02, 2025

SELL
$142.06 - $167.7 $6,392 - $7,546
-45 Reduced 12.68%
310 $51,000
Q3 2024

Oct 28, 2024

BUY
$145.48 - $167.38 $6,546 - $7,532
45 Added 14.52%
355 $57,000
Q4 2022

Sep 26, 2023

BUY
$160.2 - $179.79 $49,662 - $55,734
310 New
310 $54.8 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Decision Point Financial, LLC Portfolio

Follow Decision Point Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decision Point Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decision Point Financial, LLC with notifications on news.